Boc5, a Non-Peptidic Glucagon-Like Peptide-1 Receptor Agonist, Invokes Sustained Glycemic Control and Weight Loss in Diabetic Mice

• Haoran Su ,

  Contributed equally to this work with: Haoran Su, Min He

  Affiliation The National Center for Drug Screening, Shanghai, China

  ⨯
• Min He ,

  Contributed equally to this work with: Haoran Su, Min He

  Affiliation The National Center for Drug Screening, Shanghai, China

  ⨯
• Hongmei Li,

  Affiliation The National Center for Drug Screening, Shanghai, China

  ⨯
• Qing Liu,

  Affiliations The National Center for Drug Screening, Shanghai, China, The State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

  ⨯
• Jia Wang,

  Affiliation The National Center for Drug Screening, Shanghai, China

  ⨯
• Yiqian Wang,

  Affiliation The National Center for Drug Screening, Shanghai, China

  ⨯
• Weiwei Gao,

  Affiliation The National Center for Drug Screening, Shanghai, China

  ⨯
• Ling Zhou,

  Affiliation The National Center for Drug Screening, Shanghai, China

  ⨯
• Jiayu Liao,

  Current address: Department of Bioengineering, University of California, Riverside, California, United States of America

  Affiliation The National Center for Drug Screening, Shanghai, China

  ⨯
• Andrew A. Young,

  Current address: Amylin Pharmaceuticals Inc., San Diego, California, United States of America

  Affiliation The National Center for Drug Screening, Shanghai, China

  ⨯
• Ming-Wei Wang

  * E-mail: wangmw@mail.shcnc.ac.cn

  Affiliations The National Center for Drug Screening, Shanghai, China, The State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

  ⨯